Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-28T00:09:40.076Z Has data issue: false hasContentIssue false

CSF Electrophoresis in One Thousand Patients

Published online by Cambridge University Press:  18 September 2015

G.C. Ebers*
Affiliation:
Department of Clinical Neurological Sciences, University Hospital, University of Western Ontario, London, Ontario, Canada
D.W. Paty
Affiliation:
Department of Clinical Neurological Sciences, University Hospital, University of Western Ontario, London, Ontario, Canada
*
Division of Neurology, University Hospital, 339 Windermere Road, London, Ontario N6A 5A5 Canada
Rights & Permissions [Opens in a new window]

Summary:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Agarose and/or cellulose acetate electrophoresis was performed on the CSF of one thousand patients. In patients with clinically definite multiple sclerosis (MS) (N = 267) 92.8% had oligoclonal banding (O.B.). In patients with possible MS (N - 283) O.B. was present in 31.1%. In patients with other neurological diseases (N = 450) O.B. was present in 8% (N = 36). Nineteen non-MS patients with positive O.B. had serum bands or disorders known to be associated with local immune response. The remaining 17 patients had no explanation for the oligoclonal banding. In the majority of these MS had not been a diagnostic consideration.

CSF electrophoresis is the single most reliable laboratory lest in multiple sclerosis and deserves incorporation into the diagnostic criteria for the disease.

Type
Research Article
Copyright
Copyright © Canadian Neurological Sciences Federation 1980

References

REFERENCES

Arnaud, P., Wilson, G.D., Koistinen, J. and Fudenberg, H. (1977). Immuno-fixation after electrofocusing; improved method for specific detection of serum proteins with determination of isoelectric points. J. Immunol. Methods 16, 221231.CrossRefGoogle Scholar
Ebers, G.C. and Paty, D.W. (1979). Alkaline isoelectric focusing in multiple sclerosis. Trans. Am. Neurol. Ass. (in press).Google ScholarPubMed
Ebers, G.C., Rice, G.P. and Armstrong, H. (1980) Preparative Isoelectric Focusing in Agarose. J. Immunol. Methods (in press).CrossRefGoogle ScholarPubMed
Johnson, K.P., Arrigo, S.C., Nelson, B.J. and Ginsberg, A. (1977). Agarose electrophoresis of cerebrospinal fluid in multiple sclerosis. Neurology 27, 273277.CrossRefGoogle ScholarPubMed
Kabat, E.A., Moore, D.H. and Landow, H. (1942). An electrophoretic study of the protein components in the cerebrospinal fluid and their relationship to serum proteins. J. Clin. Invest. 21, 571577.CrossRefGoogle ScholarPubMed
Laterre, E.C., Callewaert, A. and Heremens, Y.S. (1970). Electrophoretic morphology of gammaglobulins in cerebrospinal fluid of multiple sclerosis and other disease of the nervous system. Neurology 20, 982990.CrossRefGoogle Scholar
Laurell, C.B. (1972). Composition and variation of the gel electrophoretic fractions of plasma, cerebrospinal fluid and urine. Scand. J. Clin. Lab. Invest. 29, (suppl. 124) 7182.CrossRefGoogle Scholar
Laurenzi, M.A. and Link, H. (1978). Comparison between agarose gel electrophoresis and isoelectric focusing of CSF for demonstration of oligoclonal immunoglobulin bands in neurological disorders. Acta Neurol. Scandinav. 15, 148156.Google Scholar
Link, H. and Zettervall, O. (1970). Multiple sclerosis — disturbed kappa: lambda light chain ratio of immunoglobulin G in the cerebrospinal fluid. Clin. Exp. Immunol. 6, 435438.Google Scholar
Link, H. (1973). Comparison of electrophoresis on agarogel and agarose gel in the evaluation of gamma globulin abnormalities in cerebrospinal fluid in the serum in multiple sclerosis. Clin. Chim. Acta 46, 383389.CrossRefGoogle ScholarPubMed
Lowenthal, A., Vansande, M. and Karcher, D. (1960). The differential diagnosis of neurological disease by fractionating electrophoretically the CSF-globulins. J. Neurochem. 6, 51.CrossRefGoogle Scholar
Meulemans, O. (1960). Determination of total protein in spinal fluid with sulphosalicylic and trichloracetic acid. Clinica chim. Acta 5, 757.CrossRefGoogle Scholar
Ollson, J.E., Link, H. and Muller, R. (1976). Immunoglobulin abnormalities in multiple sclerosis. J. Neurol. Sci. 27, 233245.CrossRefGoogle Scholar
Paty, D.W., Donnelly, M. and Bernardo, M.E. (1978). CSF electrophoresis: An adaptation using cellulose acetate for the identification of oligoclonal banding. Can. J. Neurol. Sci. 5, 297299.CrossRefGoogle ScholarPubMed
Rose, A.S., Ellison, G., Myers, L., et al. (1976). Criteria for the clinical diagnosis of multiple sclerosis. Neurology 26, 2022.CrossRefGoogle ScholarPubMed
Schumacher, G.A., Beebe, G., Kibler, R.F., Kurland, L.T., Kurtzke, J., Mcdowell, F., Nagler, B., Sibley, W.A., Tourtellotte, W.W. and Willmon, T.L. (1965). Problems of experimental trials of therapy in multiple sclerosis: Report by the panel of the evaluation of experimental trials of therapy in multiple sclerosis. Ann. N.Y. Acad. Sci. 122, 552568.CrossRefGoogle Scholar
Tourtellotte, W.W., Tavolato, B., Parker, J.A. and Comiso, P. (1971). Cerebrospinal fluid electroimmunodiffusion in multiple sclerosis and other neurological diseases. Arch. Neurol. 25, 345350.CrossRefGoogle Scholar
Vandvik, B., Natvig, J.B. and Niger, D. (1976). IgGI subclass restriction of oligoclonal IgG from cerebrospinal fluids and brain extracts in patient’s with multiple sclerosis and subacute encephalitides. Scand. J. Immunol. 5, 427436.CrossRefGoogle Scholar
Vandvik, B. (1977). Oligoclonal IgG and free lightchains in the cerebrospinal fluid of patients with multiple sclerosis and infectious diseases of the central nervous system. Scand. J. Immunol. 6, 913922.CrossRefGoogle Scholar
Vandvik, B., Norrby, E., Steen-Johnsen, J. and Stensvold, K. (1978). Mump meningitis — prolonged pleocytosis and occurrence of mumps virus specific oligoclonal IgG in the CSF. Europ. Neurol. 17, 1322.CrossRefGoogle Scholar
Weime, R.J. (1959). Studies on agar gel electrophoresis. Clin. Chim. Acta 4, 317321.Google Scholar